Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

NCT03369353 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03369353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2017
Completion date
January 31, 2032
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

functional gastrointestinal disorders, graft vs host disease, inflammatory bowel diseases